Evidence map›Paper›PMID 19603518›Full record

ReviewIUBMB life2009

Mammalian polyamine metabolism and function.

Anthony E Pegg

Abstract readReview
In one paragraph

Review in IUBMB life, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 412 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
412citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

412 citing papers in PubMed, 1 synthesis or guideline pooled it, 774 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Functional Characterization of the P-Type ATPases ATP13A3 and ATP13A4 as Plasma Membrane Polyamine Transporters.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Polyamines are i-motif disruptors.Molecular therapy. Nucleic acids · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

352 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anthony E PeggDepartment of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. aep1@psu.edu
In-Q-Tel · US

Funding

MAMMALIAN POLYAMINE METABOLISMR01CA018138 · NCI · UNIVERSITY OF VIRGINIA · PI FEITH, DAVID J. · 1985 to 2015
$2.8M
MAMMALIAN AMINOPROPYLTRANSFERASESR01GM026290 · NIGMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI PEGG, ANTHONY E · 1985 to 2009
$2.3M
MAMMALIAN POLYAMINE METABOLISMR37CA018138 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI PEGG, ANTHONY E · 1988 to 2004
$1.7M
NCI NIH HHS CA-018138NCI NIH HHS R01 CA018138NCI NIH HHS R37 CA018138NIGMS NIH HHS GM-26290NIGMS NIH HHS R01 GM026290
6 · The paper itself

Abstract

Polyamines are ubiquitous small basic molecules that play multiple essential roles in mammalian physiology. Their cellular content is highly regulated and there is convincing evidence that altered metabolism is involvement in many disease states. Drugs altering polyamine levels may therefore have a variety of important targets. This review will summarize the current state of understanding of polyamine metabolism and function, the regulation of polyamine content, and heritable pathological conditions that may be derived from altered polyamine metabolism.

Indexed as

AnimalsBiogenic PolyaminesMammalsBiogenic Polyamines

Identifiers

PMID19603518
PMCPMC2753421
OpenAlexW2025994995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.